Systemic complement depletion diminishes perihematomal brain edema in rats

被引:137
作者
Xi, GH
Hua, Y
Keep, RF
Younger, JG
Hoff, JT
机构
[1] Univ Michigan, Dept Surg Neurosurg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA
关键词
brain edema; cerebral hemorrhage; complement; tumor necrosis factor; rats;
D O I
10.1161/01.STR.32.1.162
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The complement cascade is activated after experimental intracerebral hemorrhage (ICH). It remains unclear, however, whether depleting the complement system will improve injury resulting from ICH. This study investigated the effects of systemic complement depletion on brain edema formation after ICH. Methods-Fifty-six pentobarbital-anesthetized Sprague-Dawley rats were used. Treatment animals were complement-depleted with cobra venom factor (CVF) (intraperitoneally). Control rats received an equal volume of saline injection (intraperitoneally). In both treatment and control rats, autologous blood (100 muL) was infused stereotaxically into the right basal gan,alia. Rats were killed 2, 24, or 72 hours later for brain water, ion, and tumor necrosis factor-alpha (TNF-alpha) measurements, for Western blot analysis, and for immunohistochemical studies. Brain edema was quantitated by wet/dry weight. TNF-alpha levels were measured by enzyme-linked immunosorbent assay. Western blot analysis was applied for C9 semiquantification. Immunohistochemistry was used to detect complement C3d, C5a, C9, and myeloperoxidase. Results-Perihematomal brain edema was reduced by systemic complement depletion at 24 hours (78.8+/-0.6% versus 81.5+/-0.8% in control, P<0.01) and 72 hours (81.5+/-1.5% versus 83.6+/-0.9% in control, P<0.05), while cerebellar water content was unaffected (78.2+/-0.3% versus 78.0+/-0.1%). Complement depletion reduced TNF-alpha production 2 hours after ICH. Immunocytochemistry showed that complement depletion significantly reduced perihematomal C9 deposition, C3d production, and the number of C5a- and myeloperoxidase-positive cells. Conclusions-Complement depletion by CVF attenuates brain edema in ICH, indicating that complement activation plays an important role in ICH-induced brain edema. Preventing complement activation may be effective in the treatment of ICH.
引用
收藏
页码:162 / 167
页数:6
相关论文
共 44 条
[21]   INTRACEREBRAL INFUSION OF THROMBIN AS A CAUSE OF BRAIN EDEMA [J].
LEE, KR ;
BETZ, AL ;
KEEP, RF ;
CHENEVERT, TL ;
KIM, S ;
HOFF, JT .
JOURNAL OF NEUROSURGERY, 1995, 83 (06) :1045-1050
[22]   Mechanisms of edema formation after intracerebral hemorrhage: Effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model [J].
Lee, KR ;
Kawai, N ;
Kim, S ;
Sagher, O ;
Hoff, JT .
JOURNAL OF NEUROSURGERY, 1997, 86 (02) :272-278
[23]   Edema from intracerebral hemorrhage: The role of thrombin [J].
Lee, KR ;
Colon, GP ;
Betz, AL ;
Keep, RF ;
Kim, S ;
Hoff, JT .
JOURNAL OF NEUROSURGERY, 1996, 84 (01) :91-96
[24]  
LUCCHESI BR, 1993, STROKE S1, V24, P41
[25]  
Männel DN, 2000, CHEM IMMUNOL, V74, P141
[26]  
Morgan BP, 1997, IMMUNOPHARMACOLOGY, V38, P43
[27]  
Mulligan MS, 1997, J IMMUNOL, V158, P1857
[28]   Requirement and role of C5a in acute lung inflammatory injury in rats [J].
Mulligan, MS ;
Schmid, E ;
BeckSchimmer, B ;
Till, GO ;
Friedl, HP ;
Brauer, RB ;
Hugli, TE ;
Miyasaka, M ;
Warner, RL ;
Johnson, KJ ;
Ward, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :503-512
[29]   THROMBIN MAY CONTRIBUTE TO THE PATHOPHYSIOLOGY OF CENTRAL-NERVOUS-SYSTEM INJURY [J].
NISHINO, A ;
SUZUKI, M ;
OHTANI, H ;
MOTOHASHI, O ;
UMEZAWA, K ;
NAGURA, H ;
YOSHIMOTO, T .
JOURNAL OF NEUROTRAUMA, 1993, 10 (02) :167-179
[30]   C5A STIMULATES SECRETION OF TUMOR NECROSIS FACTOR FROM HUMAN MONONUCLEAR-CELLS INVITRO - COMPARISON WITH SECRETION OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1-ALPHA [J].
OKUSAWA, S ;
YANCEY, KB ;
VANDERMEER, JWM ;
ENDRES, S ;
LONNEMANN, G ;
HEFTER, K ;
FRANK, MM ;
BURKE, JF ;
DINARELLO, CA ;
GELFAND, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01) :443-448